Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Mingueneau

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Novartis Foundation Symposium|May 31, 2007
Th2 lymphoproliferative disorders resulting from defective LAT signalosomesBernard Malissen, Ying Wang, Michael Mingueneau, et al.
Trends in Immunology|June 15, 2010
LAT signaling pathology: an "autoimmune" condition without T cell self-reactivityRomain Roncagalli, Michael Mingueneau, Claude Grégoire, et al.
The Journal of Experimental Medicine|February 15, 2012
Thymic negative selection is functional in NOD miceMichael Mingueneau, Wenyu Jiang, Markus Feuerer, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2015
Imbalanced signal transduction in regulatory T cells expressing the transcription factor FoxP3Dapeng Yan, Julia Farache, Michael Mingueneau, et al.
Seminars in Immunopathology|January 29, 2010
Lymphoproliferative disorders involving T helper effector cells with defective LAT signalosomesRomain Roncagalli, Michael Mingueneau, Claude Grégoire, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2009
STAT6 deletion converts the Th2 inflammatory pathology afflicting Lat(Y136F) mice into a lymphoproliferative disorder involving Th1 and CD8 effector T cellsCristel Archambaud, Amandine Sansoni, Michael Mingueneau, et al.
RMD Open|March 10, 2021
Association between T follicular helper cells and T peripheral helper cells with B-cell biomarkers and disease activity in primary Sjögren syndromeAnastasia Dupré, Juliette Pascaud, Elodie Rivière, et al.
Blood|November 18, 2005
Multiplicity and plasticity of natural killer cell signaling pathwaysSabrina Chiesa, Michael Mingueneau, Nicolas Fuseri, et al.
Rheumatology (Oxford, England)|November 3, 2016
Clinical relevance of RORγ positive and negative subsets of CD161+CD4+ T cells in primary Sjögren's syndromeLinlin Zhao, Gaetane Nocturne, Scott Haskett, et al.
Science (New York, N.Y.)|October 25, 2014
Systems biology. Conditional density-based analysis of T cell signaling in single-cell dataSmita Krishnaswamy, Matthew H Spitzer, Michael Mingueneau, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Novartis Foundation Symposium|May 31, 2007
Th2 lymphoproliferative disorders resulting from defective LAT signalosomesBernard Malissen, Ying Wang, Michael Mingueneau, et al.
Trends in Immunology|June 15, 2010
LAT signaling pathology: an "autoimmune" condition without T cell self-reactivityRomain Roncagalli, Michael Mingueneau, Claude Grégoire, et al.
The Journal of Experimental Medicine|February 15, 2012
Thymic negative selection is functional in NOD miceMichael Mingueneau, Wenyu Jiang, Markus Feuerer, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2015
Imbalanced signal transduction in regulatory T cells expressing the transcription factor FoxP3Dapeng Yan, Julia Farache, Michael Mingueneau, et al.
Seminars in Immunopathology|January 29, 2010
Lymphoproliferative disorders involving T helper effector cells with defective LAT signalosomesRomain Roncagalli, Michael Mingueneau, Claude Grégoire, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2009
STAT6 deletion converts the Th2 inflammatory pathology afflicting Lat(Y136F) mice into a lymphoproliferative disorder involving Th1 and CD8 effector T cellsCristel Archambaud, Amandine Sansoni, Michael Mingueneau, et al.
RMD Open|March 10, 2021
Association between T follicular helper cells and T peripheral helper cells with B-cell biomarkers and disease activity in primary Sjögren syndromeAnastasia Dupré, Juliette Pascaud, Elodie Rivière, et al.
Blood|November 18, 2005
Multiplicity and plasticity of natural killer cell signaling pathwaysSabrina Chiesa, Michael Mingueneau, Nicolas Fuseri, et al.
Rheumatology (Oxford, England)|November 3, 2016
Clinical relevance of RORγ positive and negative subsets of CD161+CD4+ T cells in primary Sjögren's syndromeLinlin Zhao, Gaetane Nocturne, Scott Haskett, et al.
Science (New York, N.Y.)|October 25, 2014
Systems biology. Conditional density-based analysis of T cell signaling in single-cell dataSmita Krishnaswamy, Matthew H Spitzer, Michael Mingueneau, et al.
Pageof 4